quantisnow
FeedTopReportsPricing
⌘K
Live feed
08:36:50·34d
ANALYSTRating
Roivant Sciences Ltd. logo

Bernstein initiated coverage on Roivant Sciences with a new price target

ROIV· Roivant Sciences Ltd.
Health Care
Original source

Companies

  • ROIV
    Roivant Sciences Ltd.
    Health Care

Recent analyst ratings

  • Mar 20UpdateBernstein$35.00
  • Sep 2UpdateCitigroup$16.00
  • Jul 10UpdateGoldman$19.00
  • Feb 15UpdateWolfe Research$17.00
  • Jan 5UpdatePiper Sandler$20.00
  • Dec 12UpdateDeutsche Bank$14.00

Related

  • INSIDER1d
    SEC Form 4 filed by Venker Eric
  • INSIDER1d
    SEC Form 4 filed by Pulik Richard
  • INSIDER1d
    SEC Form 4 filed by Humes Jennifer
  • INSIDER2d
    SEC Form 4 filed by Oren Ilan
  • INSIDER2d
    SEC Form 4 filed by Epperly Melissa B,
  • INSIDER2d
    SEC Form 4 filed by Momtazee James C
  • INSIDER3d
    SEC Form 4 filed by Gline Matthew
  • SEC3d
    SEC Form 144 filed by Roivant Sciences Ltd.
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022